Skip to content

The effect of Cinnopar on reducing the complications of femoral neck fractures in people aged 40 to 60 years old

The effect of Cinnopar on reducing the complications of femoral neck fractures in people aged 40 to 60 years old

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210118050072N1
Enrollment
30
Registered
2021-02-18
Start date
2021-02-19
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

femoral neck fracture. Fracture of unspecified part of neck of femur

Interventions

Intervention 1: Intervention group: people with femoral neck fractures in the ages of 40 to 60 years referred to the orthopedic ward of Golestan and Imam Khomeini hospitals in Ahvaz after division by

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patient consent to participate in the study Patients with femoral neck fractures in the ages of 40-60 years old

Exclusion criteria

Exclusion criteria: Smocking Alcohol consumption Patients with a history of diabetes, chronic hypertension, rheumatoid arthritis, calcium metabolism disorders, cancer, Paget's disease and chronic renal failure Corticosteroids and PPI user Patients with very high or very low weight

Design outcomes

Primary

MeasureTime frame
Non- union. Timepoint: X_ray at first, after 3 weeks, after 3 months and after 6 months. Method of measurement: X-ray.;Time to return to activity. Timepoint: 6 weeks and 3 months. Method of measurement: The patient walks independently and without pain and performs normal activities.;Reduce pain. Timepoint: After 3 months. Method of measurement: Visual Analogue Scale.;Fixation failure. Timepoint: 2 weeks, 6 weeks, 3 months post operation. Method of measurement: x ray.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojtaba Jafarzade Jahromi

Ahvaz University of Medical Sciences

mojtaba.jafarzade@gmail.com+98 71 5433 1137

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026